Pirfenidone Tablet 267 mg , 801 mg Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 267 mg , 801 mg
Reference Brands: Esbriet(US & EU)
Category: Respiratory Disorder
Pirfenidone is an oral antifibrotic medication used to treat idiopathic pulmonary fibrosis (IPF). It slows lung scarring, improves lung function, and reduces inflammation. Marketed as Esbriet in the US and EU, it’s taken three times daily. Common side effects include nausea, rash, and liver enzyme changes.
Product Description:
Pirfenidone is an FDA- and EMA-approved oral antifibrotic drug used to treat idiopathic pulmonary fibrosis (IPF)—a chronic lung disease marked by progressive scarring of lung tissue. Marketed under the brand name Esbriet, pirfenidone helps slow lung function decline, reduce inflammation, and limit fibrosis by inhibiting pro-fibrotic cytokines like TGF-β. Available in 267 mg and 801 mg tablet strengths, it is usually taken three times daily with food. Pirfenidone improves quality of life and delays disease progression in IPF patients. Common side effects include nausea, rash, and photosensitivity. Regular liver monitoring is advised during treatment.
Pirfenidone Tablet — third party manufacturing & bulk supply
Pirfenidone Tablet 267 mg , 801 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Pirfenidone Tablet listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Pirfenidone Tablet →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Pirfenidone is used to treat idiopathic pulmonary fibrosis (IPF), a chronic and progressive lung disease. It helps slow the decline in lung function by reducing fibrosis and inflammation in lung tissue.
Pirfenidone is a small-molecule antifibrotic and anti-inflammatory agent. Its chemical name is 5-methyl-1-phenyl-2-(1H)-pyridone.
Pirfenidone is marketed under the trade name Esbriet in the USA, EU, and UK. Generic pirfenidone is also available in several EU countries under different brand names.
Pirfenidone was originally developed and is marketed by Roche under the brand name Esbriet. Generic versions are manufactured by multiple pharmaceutical companies.
The generic name is Pirfenidone.
The brand name is Esbriet. Generic brands are also available depending on the region.
Pirfenidone is manufactured in various countries including the USA and EU member states by Roche and approved generic manufacturers.
Related Products
Salmeterol Xinafoate
Strength:
25 µg, 50 µg
Form: Inhalation
Reference Brands: Serevent (USA/LATAM/EU)
View Details
Formoterol Fumarate
Strength:
12 µg
Form: Inhalation
Reference Brands: Foradil (USA/LATAM), Oxis (India)
View Details
Ethionamide
Strength:
250 mg
Form: Tablets
Reference Brands: Generic formulations marketed under different names
View Details
Olodaterol
Strength:
2.5 mcg
Form: Inhalation solution
Reference Brands: Striverdi Respimat (USA)
View DetailsQuick Response Guaranteed | Verified Suppliers
